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Abstract
A recent meta-analysis of genome-wide association (GWA) studies identified 95 loci that influence lipid traits in the adult
population and found that collectively these explained about 25–30% of heritability for each trait. Little is known about how
these loci affect lipid levels in early life, but there is evidence that genetic effects on HDL- and LDL-cholesterol (HDL-C, LDL-
C) and triglycerides vary with age. We studied Australian adults (N = 10,151) and adolescents (N= 2,363) who participated in
twin and family studies and for whom we have lipid phenotypes and genotype information for 91 of the 95 genetic variants.
Heterogeneity tests between effect sizes in adult and adolescent cohorts showed an excess of heterogeneity for HDL-C
(pHet,0.05 at 5 out of 37 loci), but no more than expected by chance for LDL-C (1 out of 14 loci), or trigycerides (0 out 24).
There were 2 (out of 5) with opposite direction of effect in adolescents compared to adults for HDL-C, but none for LDL-C.
The biggest difference in effect size was for LDL-C at rs6511720 near LDLR, adolescents (0.02160.033 mmol/L) and adults
(0.15760.023 mmol/L), pHet = 0.013; followed by ZNF664 (pHet = 0.018) and PABPC4 (pHet = 0.034) for HDL-C. Our findings
suggest that some of the previously identified variants associate differently with lipid traits in adolescents compared to
adults, either because of developmental changes or because of greater interactions with environmental differences in
adults.
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Introduction
Plasma lipids are important and much-studied risk factors for
cardiovascular disease. For clinical use and in epidemiological
studies the main focus is on concentrations of low-density
lipoprotein cholesterol (LDL-C), high-density lipoprotein choles-
terol (HDL-C) and triglycerides. These are known to be
substantially influenced by genetic variation, with heritabilities of
40%–60% in adults and even higher (70%–80%) in adolescents.
Many novel loci affecting lipid risk factors for cardiovascular
disease have been discovered through meta-analysis of genome-
wide association (GWAS) data [1,2]. A recent and even larger
meta-analysis [3] identified 95 susceptibility loci that influence
HDL-C, LDL-C or triglycerides in adults. The significant
common variants explained 10%–12% of the total variation in
lipid levels, or around 25% of the heritability. Such results help to
define pathways between gene polymorphisms and their clinical
effects, allow some degree of risk stratification, and may identify
novel targets for risk-reducing drugs.
However, it is known that mean values for plasma lipids change
with age, and there is some evidence that the gene variants which
contribute to differences between people also change across the
lifespan. Longitudinal studies of twins across adolescence or early
adulthood [4,5,6] and cross-generational comparisons of parents
and offspring [7] support this concept. A GWAS based on
longitudinal cardiovascular risk factor data, with 525 genotyped
participants and repeated measurements covering the age range 4
to 48 years [8], showed suggestive but non-replicated SNP-by-age
interactions for two loci with LDL-C and for five (two at genome-
wide significance) for triglycerides.
Comparatively little is known about genetic loci affecting lipid
levels in early life, despite higher heritabilities in adolescents than
in adults. Practically all the published GWAS data are from adults,
often from the older adults at highest risk of cardiovascular disease.
While this is logical, atherosclerosis may start early in life, and the
question of whether the SNPs and genes already identified affect
lipid variation in childhood or adolescence is a relevant one.
Practical benefits could ensue if SNPs which affect adult levels of
risk factors, but not childhood levels, could be identified;
intervention based on a genetic profile could potentially be started
well before the risk becomes evident from conventional (pheno-
typic) risk factor assessments [8].
We have analysed lipid GWAS data from adolescents,
concentrating on the genes and SNPs shown to be important in
adults and testing for heterogeneity of allelic effects between adult
(N= 10,151) and adolescent (N= 2363) cohorts drawn from the
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Australian population. The opposite approach, of starting with
polymorphisms significantly affecting lipids in adolescence and
comparing them against adult results, is limited by the compar-
ative lack of data on young subjects. We first tested for age
heterogeneity within the adolescents and the adults separately.
After showing a lack of significant heterogeneity by age within
these two groups, allelic association tests on each cohort were
performed separately. Heterogeneity tests on each lipid trait at 91
loci with genotyping were conducted to determine whether there is
any difference in the effect of these significant reported SNPs on
plasma lipid concentrations between adolescents and adults.
Methods
Subjects
Lipid traits (HDL-C, LDL-C, triglycerides) were measured in
serum samples from twins and their families, and genome-wide
SNP markers were genotyped. The study participants consist of:
1. Adolescent twins and their non-twin siblings living in south-east
Queensland (Australia) who had participated in the Brisbane
Longitudinal Twin study [9,10,11,12]. Full details are
described in Middelberg et al. [5]. A total of 2363 participants
(1196 females and 1167 males; mean age of 14.5 years) were
genotyped.
2. Adults (twins and their family members) who participated in
studies of: (i) alcohol and nicotine use and dependence and
metabolic risk for alcoholic liver disease [13] (n = 6924); (ii)
Anxiety and Depression [14] (n = 1213); (iii) Endometriosis
[15] (n = 845); and (iv) Pre-1982 twin studies; Alcohol
Challenge and follow-up and vitamin C [16,17,18,19]
(n = 1171). A total of 10,151 individuals (6257 females and
3894 males; mean age of 45.7 years) were genotyped in these
community-recruited particpants.
There was no overlap between participation in the adolescent
and adult studies. However, some adults participated in more than
one study and many of the adolescents had phenotypic
measurements on more than one occasion. Combining all these
studies, each individual was first categorised into age groups. For
the adolescents these were 1 (age 12–13.99 years), 2 (age 14–15.99
years) or 3 (16–17.99 years). Adult groups were 4 (18–29.99 years),
5 (30–44.99 years), 6 (45–59.99 years) or 7 (age 60 years and over).
The present study includes 20,634 individuals with HDL-C, LDL-
C and triglycerides measurements and 12,514 from 5,424 families
(2,363 individuals from 1,024 adolescent families; 10,151 individ-
ual from 4,400 adult families) who had both genotype and
phenotype data. All participants (and, for subjects aged ,18 years,
their parents) gave informed written consent and all studies were
approved by the Human Research Ethics Committee of the
Queensland Institute of Medical Research.
Laboratory measurements
Serum was separated from the blood samples and stored at
270uC until analyzed. Serum cholesterol, HDL cholesterol and
triglycerides, were measured using Roche methods on a Roche
917 or Modular P analyzer (Roche Diagnostics, Basel, Switzer-
land). LDL-cholesterol was calculated using the Friedewald
equation.
Genotyping
DNA was extracted from blood samples using standard methods
and genotyped with Illumina 610K, 317K or 370K chips at CIDR
or deCODE Genetics. Data cleaning for SNP genotypes included
checking the expected relationships between individual family
members and resolving Mendelian errors [20]. Imputed genotypes
for SNPs were generated using MACH 1.0 (http://www.sph.
umich.edu/csg/abecasis/mach/index.html) [21,22] program with
the HapMap CEU I+II (release 22, build 36) reference panel. Any
imputed SNP which had r2§0:3 was included in the genotype
data.
Statistical Analysis
Distributions of lipid variables were examined and triglyceride
was log-transformed. Individuals whose results for any trait were
more than five standard deviations from the mean were excluded
for that trait. Before association analysis, the variables were adjusted
for the effects of age, squared age (age2), sex, sex6age and sex6age2
and standardized residuals were obtained. All data pre-processing
and descriptive analyses were done using STATA version 7.0 [23]
and SPSS version 17.0.2 (Mar 11, 2009). SNP family-based
association analysis was performed using ‘‘fastassoc’’ and ‘‘inverse-
Normal’’ options in MERLIN 1.1.2. [24]. To examine whether there
are differences in effect sizes within the adolescent or adult cohorts,
we first obtained the effect size, direction and standard error for
each SNP identified in Teslovich’s study [3], in each age category
from family-based association analyses. Then, heterogeneity within
the children/adolescents (that is, age categories 1–3) and within the
adults (age categories 4–7) were tested separately. As no evidence for
heterogeneity within each group was found, a heterogeneity test
contrasting effect sizes between adolescents and adults was
performed. For the initial comparisons of the different age-groups
within adolescence or within adulthood, no adjustment was made
for multiple observations from the same person at different ages.
This is a preliminary check for heterogeneity within adolescent or
adult cohorts. For the subsequent analysis (that is, the adolescent
versus adult heterogeneity tests), where there were multiple
measurements of the same trait in an individual, an average of
the values was used. For the final heterogeneity test, estimates of the
effect sizes and standard errors were calculated using MERLIN
(allowing for familial relationships) and compared between
adolescent and adult cohorts. Heterogeneity tests were performed
using METAL 1.1.2 [25].
Results
Means and standard deviations of lipid traits for males and
females in adolescent and adult cohorts are listed in Table 1.
Generally, the lipid traits have lower means in the adolescents than
the adults, as expected. Out of the 102 SNPs (at 95 loci) identified
by the Global Lipids Consortium [3], only 98 SNPs (at 91 loci)
were examined in our study; four SNPs were excluded due to poor
imputation quality score (R2,0.3) or violation of Hardy-Weinberg
equilibrium (at P,1026). Most SNPs (23/24 for HDL-C, 12/14
for LDL-C and 35/36 for triglycerides) associated with lipid
concentrations (as the lead trait) in our adult data were
directionally consistent with the Global Lipids Consortium meta-
analysis. The correlations between effect sizes reported by the
Global Lipids Consortium for the SNPs they found significant and
our effect sizes were 0.94 for HDL-C, 0.98 for LDL-C and 0.95 for
triglycerides. In adolescents, 41 out of the 98 SNPs were
significantly (p,0.05) associated with at least one of the lipid
traits (Table S1). The correlations of effect sizes between our
adolescent and the Global Lipids Consortium results were 0.84 for
HDL-C, 0.84 for LDL-C and 0.91 for triglycerides.
Heterogeneity tests generally showed no significant difference
(at p,0.05) in effect sizes between the three age groups (within
adolescents) except for LDLR and HFE on HDL-C (pHet = 0.049
Allelic Effects between Adolescents and Adults
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and 0.024), ERGIC3 on LDL-C (pHet = 0.014) and SCARB1 on
LTG (pHet = 0.031) (Tables S2, S3, S4). Similarly there was no
significant heterogeneity in effect size between the four age groups
within the adults except for UBE2L3 and PINX1 on HDL-C
(pHet = 0.020 and 0.031), COBLL1, APOE, ANGPTL3, HFE,
MAFB, HMGCR and ZNF664 on LDL-C (pHet = 0.455, 0.017,
0.032, 0.028, 0.040, 0.012, 0.046) and FLJ36070, GALNT2,
SLC39A8, PDE3A and PINX1 on triglycerides (pHet = 0.015,
0.021, 0.009, 0.024, 0.013) (Tables S2, S3, S4). Hence, no
significant heterogeneity in effect sizes was detected within the
adolescents or adults after Bonferroni correction for multiple
testing.
Heterogeneity testing between the adolescent and adult cohorts
showed there were 5 (out of 37), 1 (out of 14) and 0 (out of 24)
variants showing significant heterogeneity (p,0.05) in effect size for
HDL-C (most significant pHet = 0.016 atMC4R), LDL-C (significant
pHet = 0.013 at LDLR) and triglycerides respectively (Table 2 &
Tables S5, S6, S7). For HDL-C, but not for LDL-C or triglycerides,
there was an excess of significantly heterogeneous associations
among these 98 SNPs over expectation (Figures 1, 2, 3). The biggest
difference in effect size was the G-allele of rs6511720 (LDLR gene)
showing a 7-fold difference in association with LDL-C (effect size
of 0.03360.051 in SD unit (equivalent to 0.02160.033 mmol/L)
in adolescents and 0.17460.051 in SD (equivalent to
0.15760.023 mmol/L) in adults). Some SNPs in HDL-C were
seen to have opposite direction of effect in adolescents compared to
adults. The biggest difference in effect direction was for the A-allele
of rs4660293 in PABPC4 (20.02960.038 in SD units (equivalent to
20.00860.011 mmol/L) in adolescents; 0.06160.019 in SD unit
(equivalent to 0.02460.007 mmol/L) in adults). There were also
some SNPs showing an increase or decrease in effect size without
change in direction from adolescents to adults. In addition to
rs7134594 (geneMVK) with HDL-C, for which the effect size of the
T-allele was almost 6-fold higher in adolescents than in adults,
rs12967135 (MC4R gene) also showed a 3-fold higher in effect size of
the G-allele in adolescents compared to adults. In addition, one
variant showed a p-value of less than 0.05 in heterogeneity
between adolescents and adults in more than one trait. The effect
size of the G-allele of rs6511720 in LDLR was differentially
associated with both HDL-C (0.10260.051 in SD (equivalent to
0.02960.015 mmol/L) in adolescents; 20.01960.024 in SD
(equivalent to 20.00760.009 mmol/L) in adults; pHet = 0.032) and
LDL-C (0.03360.051 in SD (equivalent to 0.02160.033 mmol/L) in
adolescents; 0.17460.025 in SD (equivalent to 0.15760.023 mmol/L)
in adults; pHet = 0.013).
We also generated a Q-Q plot of the heterogeneity p-values
across all (<2.5 million) SNPs genome-wide. These did not show
genome-wide significant (p,561028) heterogeneity of allelic
effects between adolescents and adults (Figures S1, S2, S3), and
there was no evidence for an excess of suggestive associations
above those which would be expected by chance.
Discussion
Our study examined and compared allelic effects in 2,363
adolescents and 10,151 adults at 91 previously identified loci
known to influence high- or low-density lipoprotein cholesterol, or
triglycerides, in adults. The allelic associations found in our data
are consistent with previous reports, given the smaller number of
subjects available. We found a high correlation between effect sizes
reported by the Global Lipids Consortium for the SNPs they
found significant [3] and the effect sizes found in our adult
(r2.0.90) and adolescent (r2.0.80) results. All SNPs giving
significant associations at p,561028 in our adolescent or adult
data had been reported previously.
The novel aspect of our data is the potential to compare allelic
effects between adolescence and adulthood. Testing for heteroge-
neity between effect sizes in our adult and adolescent cohorts
showed an excess of loci showing pHet,0.05 for HDL-C (5 out of
37) and possibly for LDL-C (1 out of 14), but none showed
significant heterogeneity (pHet,0.05) for triglycerides. The Q-Q
plots of observed versus expected distributions of pHet (Figures 1, 2,
3) are consistent with this, but no single locus showed
heterogeneity after correction for multiple comparisons
(p,0.0014 for HDL-C, p,0.0036 for LDL-C or p,0.0021 for
triglycerides). To cover the possibility of differing allelic effects in
adolescents and adults at loci which were not discovered in other
adult studies or meta-analyses, we checked for significant
heterogeneity at all 2.5M genotyped or imputed SNPs, but none
was found and nor do the Q-Q plots (Figures S1, S2, S3) show
evidence for their existence.
Overall, the largest allelic association effect size (beta) was
observed at rs374261 (or rs247616 which is in complete linkage
disequilibrium, r2 = 1) of CETP gene on chromosome 16, in both
adolescents and adults. The effect estimates of rs374261 [C] on
HDL-C in adolescents and adults were comparable (adolescents:
20.027 mmol/L (equivalent to 21.09 mg/dL) and adults:
20.037 mmol/L (equivalent to 21.49 mg/dL). Even though the
estimates obtained in this study have the same directional effect as
previous studies, our estimates were much lower. The effect
obtained by Teslovich et al. [3] for rs3764261 in adults was
23.39 mg/dL and Smith et al. [8] was 22.99 mg/dL for
rs247616 in adolescents. A recent longitudinal genome-wide study
on the Bogalusa cohort examined the association between genetic
factors and development of CVD risk factors from childhood to
adulthood and reported rs247616 on chromsome 16 in CETP and
rs445925 on chromosome 19 in APOE to have significant time-
dependent effects (that is, SNP6Age interaction effects) on HDL-
Table 1. Descriptive characteristics of genotyped adolescents and adults stratified by sex.
Trait Adolescents (n =2363) Adults (n=10151)
Male (n =1167) Female (n=1196) Male (n=3894) Female (n =6257)
N Mean SD N Mean SD N Mean SD N Mean SD
Age (years) 1167 14.46 1.54 1196 14.62 1.68 3894 46.50 12.73 6257 45.21 13.10
HDL-C(mmol/L) 1164 1.34 0.29 1196 1.43 0.29 3875 1.33 0.35 6224 1.64 0.41
LDL-C(mmol/L) 1160 2.38 0.67 1196 2.47 0.61 3656 3.41 0.91 6122 3.21 0.92
Triglycerides (mmol/L) 1164 1.26 0.63 1196 1.15 0.50 3892 2.21 1.40 6248 1.61 0.97
doi:10.1371/journal.pone.0035605.t001
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C and LDL-C respectively [8]. Our results at CETP (pHet = 0.027
for rs374261, r2 = 1.0 with rs247616) confirms the Bogalusa study
interaction effect for HDL-C, but we did not find adult-adolescent
heterogeneity for LDL-C at APOE.
Our other results may also be contrasted with those reported
from the longitudinal, repeated-measures Bogalusa study [8]. Our
numbers in both the adolescent and the adult groups are
substantially greater, but we have insufficient subjects studied at
both ages (adolescent and adult) for useful repeated-measures
analysis across these stages of life. The Bogalusa study showed
SNP6age interactions at p,561028 for triglycerides at two SNPs
(rs7890572 in IL1RAPL1 on the X chromosome and rs12280753
between CADM1 and BUD13 on chromosome 11) and suggestive
interactions (p,1026) for triglycerides at rs13290397 (PSAT1/
CHCHD9, chromosome 9), rs6726786 (FSHR/NRXN1, chromo-
some 2) and rs12330441 (IL20RB/SOX14, chromosome 3). They
also found suggestive (again, p,1026) interaction results for LDL-
C at rs8073909 (AKAP1/MSI2, chromosome 17) and rs11258628
(FRMD4A, chromosome 10). As none of these loci were reported
as significant in the Global Lipids Consortium meta-analysis and
were therefore not prioritised in our comparison, we checked them
for heterogeneity between our adults and adolescents but only
found rs8073909 on chromosome 17 (AKAP1/MSI2) to show
significant heterogeneity (pHet,0.05) for LDL. We also examined
the allelic effects for these SNPs across the seven age groups in our
study. We noted that there is an increasing trend of allelic effects in
minor allele across age groups for rs8073909 (Figure S4).
However, as shown in the Figures, there are no significant
differences between allelic effects between the different age groups.
One limitation in our study is our adolescent data did not
account for pubertal status. As it is known that during puberty the
changes of lipid levels differ between male and female adolescents
[26,27], this is potentially relevant but information on puberty
status was not available. However, we did make adjustments for
age, sex and age6sex interaction.
There is evidence of lipid changes during therapy for
endometriosis patients [28]. To confirm the results in Table 2,
we performed a heterogeneity test between samples that consisted
of adults from the endometriosis study and others (that is,
excluding the endometriosis adults) to ensure that our results are
not biased by including participants from that study. We did not
find any significant heterogeneity (pHet.0.05) between this and the
other studies (Table S8). In relation to the other studies (related to
alcohol, smoking and anxiety), the focus of these studies was on
causes of the condition in the community and the subjects on
whom we base our results are similar in relevant respects to the
general community. In assessing differences between genetic
causes of variation in adolescence and adulthood we suggest that
it is better to be inclusive of people with poor lifestyles or pre-
clinical disease rather than use only ‘healthy’ controls. Only a
small proportion of the participants will be clinically affected cases.
In summary, our study suggests that there is an excess of loci
showing nominally significant heterogeneity (pHet,0.05) between
effect sizes in adults and adolescents for HDL-C. These loci
associate differently with lipid traits in adolescents compared to
adults. However, no locus showing strong evidence of heteroge-
neity was found. The Bogalusa study reported seven possible loci
showing significant or suggestive SNP6Age interaction effects but
our study found only one locus out of their seven showing a
significant heterogeneity p-value,0.05. Larger studies with more
detailed characterisation of age-related and pubertal changes
across childhood and adolescence will be required to reach firm
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Figure 2. Quantile-quantile plot of observed against expected heterogeneity P-value for allelic associations with LDL-C. The grey
shaded area represents the 95% confidence interval.
doi:10.1371/journal.pone.0035605.g002
Figure 1. Quantile-quantile plot of observed against expected heterogeneity P-value for allelic associations with HDL-C. The grey
shaded area represents the 95% confidence interval.
doi:10.1371/journal.pone.0035605.g001
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Supporting Information
Figure S1 Quantile-quantile plot of observed against
expected heterogeneity P-value for allelic associations
with HDL-C for all SNP with 95% confidence interval
(grey shaded area).
(TIF)
Figure S2 Quantile-quantile plot of observed against
expected heterogeneity P-value for allelic associations
with LDL-C for all SNP with 95% confidence interval
(grey shaded area).
(TIF)
Figure S3 Quantile-quantile plot of observed against
expected heterogeneity P-value for allelic associations
with triglycerides for all SNP with 95% confidence
interval (grey shaded area).
(TIF)
Figure S4 Alleleic effects and Error bars SE for each estimated
effect of minoar allele by age group at (A) rs247616 (CETP) on
HDL-C; (B) rs445925 (APOE) on LDL-C; (C) rs8073909 (AKAP1/
MSI2) on LDL-C; (D) rs11258628 (FRMD4A) on LDL-C; (E)
rs7890572 (IL1RAPL1) on triglycerides; (F) rs12280753 (CADM1)
on triglycerides; (G) rs13290397 (PSAT1/CHCHD9) on triglycer-
ides; (H) rs6726786 (FSH/NRXN1) on triglycerides and (I)
rs12330441 (IL20RB/SOX14) on triglycerides.
(PDF)
Table S1 Association of loci significant with at least one lipid
traits in adolescents (n = 2,336), comparing results from the Global
lipids Consortium (Teslovich et al) for adult.
(PDF)
Table S2 Heterogeneity P-values within adolescents and adults
in HDL-C in 98 SNPs examined.
(PDF)
Table S3 Heterogeneity P-values within adolescents and adults
in LDL-C in 98 SNPs examined.
(PDF)
Table S4 Heterogeneity P-values within adolescents and adults
in triglycerides in 98 SNPs examined.
(PDF)
Table S5 Heterogeneity test between adolescents and adults in
HDL-C in 98 SNPs examined.
(PDF)
Table S6 Heterogeneity test between adolescents and adults in
LDL-C in 98 SNPs examined.
(PDF)
Table S7 Heterogeneity test between adolescents and adults in
triglycerides in 98 SNPs examined.
(PDF)
Table S8 The locus/phenotype combinations of EN-others
heterogeneity tests reported Table 2.
(PDF)
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